Both major forms of diabetes -- type-1 and type-2 -- result from the same mechanism, suggests a 20-year-long research.
Researchers form Universities of Manchester and Auckland found that type-1 and type-2 diabetes both are caused by the formation of toxic clumps of a hormone called amylin.
Diabetes is caused when the pancreas stops producing two hormones, insulin and amylin, which regulate glucose in the blood.
However, some of the amylin that is produced can get deposited around cells in the pancreas as toxic clumps which then, in turn, destroy those cells that produce insulin and amylin.
The consequence of this cell death is diabetes.
"The difference is that the disease starts at an earlier age and progresses more rapidly in type-1 compared to type-2 diabetes because there is more rapid deposition of toxic amylin clumps in the pancreas," researchers noted.
The team expects to have potential medicines ready to go into clinical trials in the next two years and it is anticipated that these will be tested in both type-1 and type-2 diabetic patients.
The research was published in the Journal of the Federation of American Societies for Experimental Biology.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
